Skip to main content
Premium Trial:

Request an Annual Quote

American Pathology Partners to Promote MDxHealth Test

NEW YORK (GenomeWeb) – MDxHealth said today that American Pathology Partners will promote and co-market the firm's ConfirmMDx for Prostate Cancer test in the US.

American Pathology Partners is building a network of pathology labs in the US and has partnered in that effort with UniPath in Denver, Palm Beach Pathology in West Palm Beach, Fla., and Eastern Carolina Pathology in Wilson, NC. MDxHealth said the agreement extends its customer base to pathologists serving urologists in key geographic markets.

Financial and other terms of the agreement weren't disclosed.

ConfirmMdx is an epigenetic assay that helps urologists distinguish patients with true-negative biopsies from those at risk for occult cancer.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.